For ABA practices and diagnostic providers using the EarliPoint System as part of the autism evaluation process, one of the recurring operational questions is how to explain the evaluation to families. The technology is unfamiliar to many parents. The questions families ask tend to follow predictable patterns. And the framing the practice uses can meaningfully affect family engagement with both the evaluation and the subsequent intervention pathway.
This piece walks through how to explain EarliPoint to families in ways that are clear, accurate, and accessible. The intent is to give practice teams a working framework rather than a script.
What EarliPoint Actually Is
The starting point is the canonical description. The EarliPoint System is an FDA-cleared medical device that aids qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder in children 16 to 95 months old who are at risk based on concerns from a parent, caregiver, or healthcare provider. It uses eye-tracking technology to measure how a child looks at brief video scenes. The qualified clinician interprets the structured output and makes the diagnostic determination. The tool complements clinical judgment, it doesn’t replace it.
That language is the regulatory and clinical foundation for everything else. The practical task is translating it into terms families understand without losing accuracy.
How Families Typically Describe the Questions They Have
In conversations with families before and after evaluation, the questions tend to cluster into a few categories.
What will my child experience during the evaluation?
Most parents want a clear, concrete picture of what the evaluation looks like for their child. The answer is straightforward: the child sits with the device, watches a short series of videos for about 12 minutes, and the device captures where the child is looking throughout. There’s no invasive component. The child doesn’t have to perform a task or speak. The behavior technician administering the session supervises and ensures the child is comfortable.
Is this safe?
The device is FDA-cleared, which families generally recognize as a meaningful regulatory standard for medical devices. The eye-tracking technology is non-contact and non-invasive. It captures information about where the child looks. It doesn’t deliver anything to the child or measure anything beyond visual attention.
Is this a test my child can pass or fail?
This is one of the most common questions and one of the most important to answer carefully. The evaluation doesn’t have a pass or fail. It captures information about how the child looks at social scenes, which the qualified clinician uses alongside other clinical information to inform their diagnostic assessment. The result isn’t a score the family or child needs to perform against.
Why is this faster than what other providers do?
Families who have been on waiting lists for traditional evaluation often want to understand why a particular provider can offer shorter timing. The honest answer is that the technology allows the assessment portion of the evaluation to be conducted more efficiently. The behavior technician administers it. The qualified clinician interprets it. The full clinical evaluation still includes parent interview, developmental history, and other components. The compression is specifically in the assessment piece.
Will this give us a diagnosis on its own?
No. The EarliPoint output is one input the qualified clinician uses to inform their diagnostic determination. Families should understand that the diagnostic decision is the clinician’s, not the device’s. That distinction matters both clinically and in how families understand what the evaluation produces.
Framing the Conversation
A useful structure for the family conversation has three parts.
Set context. Acknowledge that autism evaluation has historically taken a long time and required substantial appointment time. Explain that the practice uses an FDA-cleared technology that supports a more efficient evaluation, which is part of why the family is being scheduled in a reasonable window rather than a months-long wait.
Describe what the child will experience. Walk through the assessment session in concrete terms. Twelve minutes. Sitting with the device. Watching videos. Non-invasive. Supervised by the technician. No task the child has to perform.
Clarify what the evaluation produces. Make explicit that the clinician interprets the structured output along with parent interview, developmental history, and other clinical information, and that the diagnostic determination is the clinician’s. The technology supports the work; it doesn’t make the decision.
This structure tends to produce more confident family engagement than approaches that focus on technical capability or that under-explain what the assessment involves.
A Few Specific Framings to Avoid
A handful of phrasings tend to create confusion or concern even when they’re not intended to.
“The machine will tell us whether your child has autism.” This isn’t accurate. The qualified clinician makes the diagnostic determination. The device provides structured information that supports that determination. Using language that implies the device decides creates inaccurate expectations.
“Your child will be tested.” Some families hear “tested” as something the child has to perform on. The assessment doesn’t require performance. Describing it as an observation or measurement rather than a test tends to land more clearly.
“It’s quick, so the result might not be as thorough.” Families occasionally interpret a faster evaluation as a less complete one. The accurate framing is that the assessment portion is more efficient because the technology compresses the time required, not because the evaluation is less rigorous overall. The full clinical evaluation still includes the same components as a traditional one.
Family-Facing Materials That Tend to Work Well
Practices that have integrated EarliPoint into their evaluation workflow tend to develop a few family-facing materials over time:
- A pre-visit explanation of what the assessment involves (often a one-page document or web page)
- A short video the family can watch ahead of time showing what the assessment session looks like
- A clear post-evaluation feedback session structure where the clinician walks the family through what was observed and what the diagnostic determination is
Each of these can be developed internally, and EarliPoint provides reference materials that practices can adapt. The principle is that families who have clear, accurate, accessible information about the evaluation engage differently than families encountering the technology for the first time in the evaluation room.
Closing Thought
The family-facing communication around new clinical technology tends to be the part of implementation that practices underinvest in. The clinical and operational work of adopting the technology gets meaningful attention. The communication work, which is what shapes the family’s experience of the technology, often gets developed informally over time rather than being designed deliberately.
Practices that invest in family communication as an explicit part of the EarliPoint adoption process tend to see better family engagement with the evaluation, clearer post-evaluation conversations, and more reliable follow-through into the recommended intervention pathway.
For practices working through how to develop family-facing materials for an EarliPoint workflow, our provider network team maintains reference materials that can be adapted to a specific practice’s context.
